AF
OLMA icon

Allworth Financial’s Olema Pharmaceuticals OLMA Stock Holding History

Allworth Financial’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.07K Buy
485
+120
+33% +$1.61K ﹤0.01% 4010
2026
Q1 		$5.44K Sell
365
-7
-2% -$156 ﹤0.01% 3911
2025
Q4 		$9.3K Buy
+372
New +$6.62K ﹤0.01% 3321

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Allworth Financial's OLMA Position: Q2 2026 in Review

Allworth Financial increased its Olema Pharmaceuticals (OLMA) stake by 33% in Q2 2026, buying an estimated $1.61K and bringing the position to 485 shares worth $6.07K. The position accounts for ﹤0.01% of the portfolio, ranked #4010.

Allworth Financial first reported a position in OLMA in Q4 2025 and has held it in 3 quarters since. The position peaked at $9.3K in Q4 2025. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Allworth Financial held 485 shares of Olema Pharmaceuticals worth $6.07K as of Q2 2026.
  • Allworth Financial bought 120 Olema Pharmaceuticals shares in Q2 2026, an estimated $1.61K.
  • Olema Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4010 holding.
  • Allworth Financial first reported a position in Olema Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Allworth Financial's Olema Pharmaceuticals position peaked at $9.3K in Q4 2025.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.